All results

1 results for mind motion

• REPLENISH

  The purpose of this study is to demonstrate the efficacy and safety of secukinumab 300 milligram (mg) and 150 mg administered subcutaneously (s.c.) for 52…

  Ages

  50 Years - N/A

  Sexes

  All